骨科器械的监管:对研究和创新的未来影响
Claire A Donnelley1, Vincent J Devlin2, Mitchel B Harris3
1Institute for Global Orthopaedics and Traumatology, Department of Orthopaedic Surgery, University of California, San Francisco, San Francisco, CA.
概括
驾骨科器械复杂的监管环境对于创新至关重要. 工业界,监管机构,如食品和药物管理局 (FDA) 和组织之间的合作有助于安全有效的设备开发和市场后监督.
科学领域:
- 骨科器械的开发和监管.
- 医疗器械生命周期管理.
- 医疗保健中的监管事务.
背景情况:
- 整形医疗器械的开发范围从概念到市场后监测.
- 这个过程涉及到各种各样的利益相关者,包括行业,监管机构,医疗保健提供者和患者.
- 全球监管差异,特别是美国,欧洲经济区和英国之间的差异,影响了发展途径.
研究的目的:
- 概述整体产品生命周期的骨科设备.
- 检查监管机构,特别是FDA在设备批准中的作用.
- 讨论监管要求对行业竞争和创新的影响.
主要方法:
- 对美国和全球医疗器械监管框架的分析.
- 检查FDA的分类系统和市场前提交类型.
- 审查行业趋势,包括市场整合和定价压力.
主要成果:
- 美国食品和药物管理局采用三级分类系统,以确保设备的安全性和有效性.
- 监管障碍可能导致市场整合,可能会降低竞争.
- 美国食品和药物管理局 (FDA) 提供提交前协助,以促进早期合作.
- 骨科组织可以通过临床数据注册表支持市场后监测.
结论:
- 有效的监管,行业合作和市场后监测对于安全的骨科设备创新至关重要.
- 临床数据注册表对于跟踪患者结果和改进未来设备设计至关重要.
- 不断变化的环境需要在监管,行业和患者治疗结果之间不断适应.
更多相关视频
09:48A Friction Testing-Bioreactor Device for Study of Synovial Joint Biomechanics, Mechanobiology, and Physical Regulation
Published on: June 2, 2022
2.9K
07:28Imaging Cell Viability on Non-transparent Scaffolds — Using the Example of a Novel Knitted Titanium Implant
Published on: September 7, 2016
11.4K
相关概念视频
01:25Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
01:03Drug Control Governance: Regulatory Bodies and Their Impact
184
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with...
184